fda tirzepatide Grants a New Indication for Obesity Management FDA approves weight-loss drug Zepbound

The injectable nature of the medication means TSA or other security agencies may ask about it

doi: 10.3389/fneur.2025.1635441 Received 30 May 2025 Accepted 14 July 2025 Published 30 July 2025 Volume 16 - 2025 Edited by Vassiliy Tsytsarev, University of Maryland, United States Reviewed by Mikhail Inyushin, Central University of the Caribbean, Puerto Rico Megha Mete, Srinath University, India Updates Copyright 2025 Xu, Dong, Yuan, Chen, Shu and Yu

During pregnancy, it may also help prevent gestational diabetes

Cushing syndrome in the McCune-Albright syndrome

Prioritizing high-protein foods, complex carbohydrates, leafy greens, healthy fats, and hydration can dramatically improve how you feeland enhance your weight-loss results

Multiple studies have demonstrated that infant exposure through breast milk is clinically insignificant, with no adverse effects reported